Advice on the use of eXroid, using direct current electrotherapy to blood vessels of internal haemorrhoid to shrink haemorrhoids, to aid local decision making
Advice on the use of PIUR tUS for abdominal aortic aneurysm surveillance and endovascular aneurysm repair endoleak detection to aid local decision making
Summary of the evidence on doxylamine/pyridoxine (Xonvea) for treating nausea and vomiting of pregnancy in women aged 18 years and older to inform local NHS
Advice on the use of Danis stent for acute oesophageal variceal bleeds to aid local decision making
Advice on the use of HemaClear for bloodless surgical field during limb surgery to aid local decision making
Advice on the use of the OPTIMIZER smart system for managing heart failure to aid local decision making
Advice on the use of superDimension Navigation System to help diagnostic sampling of peripheral lung lesions to aid local decision making
Advice on the use of MR-proADM test for use with clinical deterioration scores in cases of suspected infection to aid local decision making
Advice on the use of Endo-SPONGE for colorectal anastomotic leakage to aid local decision making
KTT24 Suicide prevention: optimising medicines and reducing access to medicines as a means of suicide Key points
KTT23 Shared decision making Key points In the context of medicines optimisation, shared
Advice on the use of Optowire (sterile, fibreoptic-based, disposable guide wire) for measuring fractional flow reserve (FFR) to aid local decision making
Advice on the use of Leukomed Sorbact for preventing surgical site infection (SSI) to aid local decision making
KTT12 Type 2 diabetes mellitus: medicines optimisation priorities Key points The NICE
KTT18 Multimorbidity and polypharmacy Key points Multimorbidity is associated with
KTT16 Anticoagulants, including direct-acting oral anticoagulants (DOACs) Key points
KTT3 Lipid-modifying drugs Key points The NICE guideline on cardiovascular disease:
KTT7 Antipsychotics in people living with dementia Key points The risks and limited
KTT14 Wound care products Key points A large number of wound dressings are available
KTT17 Acute kidney injury (AKI): use of medicines in people with or at increased risk of AKI Key points
KTT6 Hypnotics Key points The risks associated with hypnotics (including melatonin)
KTT21 Medicines optimisation in chronic pain Key points Controlling chronic pain can
KTT19 Psychotropic medicines in people with learning disabilities whose behaviour challenges Key points
KTT20 Safer insulin prescribing Key points Several new insulin products have been launched
KTT5 Asthma: medicines safety priorities Key points Inhaled corticosteroids (ICS) are
KTT9 Antimicrobial stewardship: prescribing antibiotics Key points Antimicrobial resistance
KTT22 Chemotherapy dose standardisation Key points Chemotherapy dose standardisation
Summary of the evidence on antimicrobial prescribing of meropenem with vaborbactam (Vaborem) to inform local NHS planning and decision making
Advice on the use of UroShield for preventing catheter-associated urinary tract infections (CAUTI) to aid local decision making
Advice on the use of SuperNO2VA for the relief of upper airway obstruction in people with obstructive sleep apnoea to aid local decision making
Advice on the use of Alpha-Stim AID for anxiety to aid local decision making
Advice on the use of InterDry for intertrigo (inflammatory skin rash) to aid local decision making
Advice on the use of AmnioSense (non-invasive diagnostic pad/liner) for unexplained vaginal wetness in pregnancy to aid local decision making
Advice on the use of the V.A.C. Veraflo Therapy system for infected wounds to aid local decision making
The proportion of people who have had an acute stroke who receive thrombolysis for stroke Subject(s): Stroke and ischaemic attack
The proportion of people who have had or are having a stroke who are admitted to an acute stroke unit within 4 hours of arrival to hospital
The proportion of patients who have had an acute stroke who spend 90% or more of their stay on a stroke unit Subject(s): Stroke and
NM169
The percentage of patients aged 80 years or over with peripheral arterial disease in whom the last blood pressure reading (measured in the preceding...
The percentage of patients registered at the practice aged 65 years and over who have been diagnosed with one or more of the following conditions:...
NICE indicators. NM53 hypertension guidance.
The percentage of patients diagnosed with hypertension (diagnosed on or after 1 April 2009) who are given lifestyle advice in the preceding 12 months...
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure.
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with an ACE-I or ARB
NM171
The percentage of patients with a new diagnosis of depression or anxiety and a FAST score of ≥3 or AUDIT-C score of ≥5 in the preceding 12 months, who
The percentage of patients with a new diagnosis of depression or anxiety in the preceding 12 months who have been screened for hazardous drinking...
The percentage of patients aged 75 or over with a fragility fracture on or after 1 April 2012, who are currently treated with an appropriate...
The percentage of patients on lithium therapy with a record of lithium levels in the therapeutic range within the previous 4 months Subject(s):
The percentage of patients on lithium therapy with a record of serum creatinine and TSH in the preceding 9 months Subject(s): Bipolar,